Ypsomed Holding AG (SWX:YPSN)
345.80
+6.80 (2.01%)
Jun 4, 2026, 5:30 PM CET
Ypsomed Holding AG Company Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services.
It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors.
Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Ypsomed Holding AG

| Country | Switzerland |
| Founded | 1984 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,025 |
| CEO | Simon Michel |
Contact Details
Address: Brunnmattstrasse 6 Burgdorf, 3401 Switzerland | |
| Phone | 41 34 424 41 11 |
| Website | ypsomed.com |
Stock Details
| Ticker Symbol | YPSN |
| Exchange | SIX Swiss Exchange |
| Fiscal Year | April - March |
| Reporting Currency | CHF |
| ISIN Number | CH0019396990 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Frank Mengis | Chief Operating Officer, Deputy Chief Executive Officer Member of Executive Board |
| Simon Michel | Chief Executive Officer, Member of Executive Board and Member of the Board |
| Samuel Kunzli | Chief Financial Officer and Member of Executive Board |
| Ulrike Bauer | Chief Business Officer and Member of Executive Board |
| Michael Zaugg | Chief Corporate Officer and Member of Executive Board |
| Dr. Nicolas Meyer | Chief Legal Officer and Secretary and Member of Executive Board |
| Sam Ghezelbash | Head of Investor Relations and M&A |